Aptevo Therapeutics Inc. sell Global_Player
Start price
12.12.22
/
50%
€7.11
Target price
12.12.23
-
Performance (%)
-63.02%
End price
13.12.22
€2.63
Summary
This prediction ended on 13.12.22 with a price of €2.63. Global_Player correctly predicted massive losses of -63.02% for Aptevo Therapeutics Inc.. Global_Player has 50% into this predictionUnfortunately, there is no listed company called Aptevo Therapeutics with the symbol APVOV. However, there is a company with the symbol APVO. Aptevo Therapeutics is a biotechnology company that focuses on the discovery, development, and commercialization of novel oncology and hematology therapeutics. The company's product portfolio includes treatments for a variety of conditions such as hemophilia, immune disorders, and cancer. Their approach involves using genetically engineered proteins to target specific diseases and their therapies have shown promising results in clinical trials.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Aptevo Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% |
Comments by Global_Player for this prediction
In the thread Aptevo Therapeutics Inc diskutieren
Sell Aptevo Therapeutics Inc.